Leveraging molecular structure and bioactivity with chemical language models for de novo drug design
Michaël Moret(ETH Zurich), Gisbert Schneider(ETH Zurich)
Cited by 156
Related Papers
Designing antimicrobial peptides: form follows function
|Nature Reviews Drug Discovery|2011|2k
Predicting drug metabolism: experiment and/or computation?
|Nature Reviews Drug Discovery|2015|500
DOGS: Reaction-Driven de novo Design of Bioactive Compounds
|PLoS Computational Biology|2012|264